Aurora Cannabis R&D Spending Growth & History (ACB)
Aurora Cannabis's r&d spending was $4.0M for fiscal 2026.
View full Aurora Cannabis company overviewAurora Cannabis annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $4.0M | $346,000 | +9.41% |
| 2025 | 2025-03-31 | $3.7M | $104,000 | +2.91% |
| 2024 | 2024-03-31 | $3.6M | −$1.3M | −27.41% |
| 2023 | 2023-03-31 | $4.9M | — | — |
| 2022 | 2022-06-30 | $10.4M | −$1.1M | −9.24% |
| 2021 | 2021-06-30 | $11.4M | −$14.6M | −56.02% |
| 2020 | 2020-06-30 | $26.0M | $11.2M | +76.12% |
| 2019 | 2019-06-30 | $14.8M | $13.1M | +780.17% |
| 2018 | 2018-06-30 | $1.7M | — | — |
Aurora Cannabis quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $941,000 | $112,000 | +13.51% |
| Q4 2026 | 2026-03-31 | $986,000 | — | — |
| Q3 2026 | 2025-12-31 | $1.3M | — | — |
| Q2 2026 | 2025-09-30 | $904,000 | — | — |
| Q1 2026 | 2025-06-30 | $829,000 | — | — |
Aurora Cannabis r&d spending trends
Between the periods ended 2018-06-30 and 2026-03-31, Aurora Cannabis's r&d spending increased from $1.7M to $4.0M, a change of $2.3M. The latest reported quarter, Q1 2027, shows $941,000.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aurora Cannabis source filings ↗